Use of Care Bundle in Acute Kidney Injury
Impact of Compliance With a Care Bundle on Acute Kidney Injury Outcomes
1 other identifier
observational
944
1 country
1
Brief Summary
This study is a service evaluation to assess the impact of compliance of Acute Kidney Injury care bundle (AKI-CB) on clinical and renal outcomes. The AKI care bundle is coupled with an interruptive electronic alert, which is triggered by the first attempt to order blood tests or medications on patients who have been identified as having AKI by the electronic recognition from serum creatinine results. The interruptive alert will warn the clinician about AKI and request them to complete the AKI care bundle. Once the AKI care bundle is completed, the clinician is able to request blood tests or medication. The clinician will be able to override the alert only after stating the reason. Education with respect to importance of AKI and the AKI-CB is provided every four months when junior doctors rotated through different specialities and also at clinical governance days. The investigators will compare AKI episodes, which have the AKI-CB completed early (defined as within 24 hours of availability of the blood results) with those who either had the AKI-CB completed late (defined as after 24 hours of availability of the blood results) or not completed at all. The AKI patients who either had the AKI-CB completed late or not completed will be considered as not having the AKI-CB completed for this analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 23, 2015
CompletedFirst Posted
Study publicly available on registry
August 27, 2015
CompletedAugust 27, 2015
August 1, 2015
1.4 years
August 23, 2015
August 25, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
This is the average follow up
1 year
Secondary Outcomes (2)
Length of stay
10 days
Severity of AKI as measured by AKI stages
10 days
Eligibility Criteria
All adults patients with acute kidney injury
You may qualify if:
- All episodes of acute kidney injury in adults patients
You may not qualify if:
- Age less than 17 years
- Patients without acute kidney injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Derby Hospital NHS Foundation Trust
Derby, Derbyshire, DE22 3NE, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nitin V Kolhe, MD, DM
Derby Teaching Hospital NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Nephrologist
Study Record Dates
First Submitted
August 23, 2015
First Posted
August 27, 2015
Study Start
August 1, 2013
Primary Completion
January 1, 2015
Study Completion
July 1, 2015
Last Updated
August 27, 2015
Record last verified: 2015-08